Your session is about to expire
← Back to Search
Behavioral Activation for Social Connectedness
N/A
Recruiting
Led By Renée L Pepin, PhD
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a therapy that helps older adults who feel isolated by encouraging them to do activities they enjoy, aiming to make them happier and more socially connected.
Who is the study for?
This trial is for older adults over 60 who are part of a home-delivered meals program and feel disconnected socially. It's not for those with significant depression, suicide risk, cognitive issues, severe hearing or vision problems that prevent using tele-conferencing tools, non-English speakers, people unable to consent, minors, pregnant women or prisoners.
What is being tested?
The study tests a Brief Behavioral Activation technique aimed at improving social connections among seniors. The effectiveness will be measured by staff from the Area Agency on Aging who work with these individuals.
What are the potential side effects?
Since this is a behavioral intervention focusing on social activities rather than medication or medical procedures, traditional physical side effects are not expected. However, participants may experience emotional discomfort.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Social Connectedness A, Baseline
Social Connectedness A, Change from Baseline to Post Intervention
Social Connectedness A, Change from Post Intervention to Follow Up
+3 moreSecondary study objectives
Intervention Reach
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Brief Behavioral Activation for Improving Social ConnectednessExperimental Treatment1 Intervention
Active, 6 session Brief Behavioral Activation for Improving Social Connectedness
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Behavioral Activation (BA) is a common treatment for improving social connectedness, focusing on encouraging individuals to engage in meaningful and positively reinforcing activities. This approach helps counteract patterns of avoidance and withdrawal by promoting active participation in social and recreational activities.
By doing so, BA enhances mood, builds social relationships, and reduces feelings of isolation, which are crucial for individuals experiencing low social connectedness.
Post-treatment stage of change predicts 12-month outcome of treatment for alcohol problems.
Post-treatment stage of change predicts 12-month outcome of treatment for alcohol problems.
Find a Location
Who is running the clinical trial?
Dartmouth-Hitchcock Medical CenterLead Sponsor
539 Previous Clinical Trials
2,539,705 Total Patients Enrolled
Renée L Pepin, PhDPrincipal InvestigatorDartmouth-Hitchcock Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Brief Behavioral Activation for Improving Social Connectedness
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.